EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Hypothalamic–Pituitary–Adrenal Axis Dysfunction in People With Cancer: A Systematic Review

Natalie G Kanter iD, Sarah Cohen-Woods iD, David A Balfour iD, Morton G Burt iD, Alison L Waterman iD, Bogda Koczwara iD

Cancer Medicine · 2024-11 · 13 (22)

DOI: 10.1002/cam4.70366 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Medicine, online erschienen am 21.11.2024. Verfasst von Natalie G Kanter und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia. Hauptthemen laut MEDLINE: Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Neoplasms, Hydrocortisone. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cancer can be a source of significant psychological and physical stress. Prolonged stressful stimuli can influence the stress response, mediated by the hypothalamic–pituitary–adrenal (HPA) axis. However, there is limited literature investigating HPA axis function in patients with cancer.

Methods

A systematic literature review of case–control studies was conducted comparing individuals with and without cancer examining the HPA axis function. Databases (MEDLINE, PubMed, Scopus) were searched from inception to May 2023.

Results

Seventeen studies met eligibility criteria: nine unstimulated‐cortisol studies and eight reporting the effect of HPA stimulation or suppression. Sixteen studies reported altered levels of HPA function in cancer patients relative to controls, including 12 reporting increased baseline or hyperactive cortisol responses, and four—decreased baseline cortisol or blunted cortisol responses, two of which had patient groups with now known cortisol‐suppressing treatments. HPA dysfunction was observed in patients of both sexes, diverse ages, stages of cancer and cancer treatments. Six papers reported on clinical outcomes with cases experiencing higher levels of fatigue, stress, poor memory, poor well‐being and disturbed sleep. There was significant heterogeneity in methodologies across the studies.

Conclusion

HPA dysfunction was common in patients with cancer relative to cancer‐free controls. The majority of studies in cancer reported an increased baseline cortisol and increased response to HPA stimulation. There is a need for well‐powered studies using standardised methodology examining the mechanisms of HPA dysregulation and their health outcomes, to enable the development of appropriate tools for the diagnosis and management of HPA dysfunction in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypothalamo-Hypophyseal SystemPituitary-Adrenal SystemNeoplasmsHydrocortisoneHumansStress, PsychologicalCase-Control StudiesMaleFemale

Stichwörter der Autor:innen

glucocorticoidsneoplasmphysiologicalpituitary–adrenal systemstresssystematic review

Substanzen

Hydrocortisone

Autor:innen und Institutionen

  • College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
  • Flinders University Institute for Mental Health and Wellbeing, Flinders University, Bedford Park, South Australia, Australia.
  • College of Education, Psychology, and Social Work, Flinders University, Bedford Park, South Australia, Australia.
  • Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
  • Southern Adelaide Diabetes and Endocrine Services, Flinders Medical Centre, Bedford Park, South Australia, Australia.
  • Department of Medical Oncology, Flinders Medical Centre, Bedford Park, South Australia, Australia.

ORCID-Profile: Natalie G Kanter, Sarah Cohen-Woods, David A Balfour, Morton G Burt, Alison L Waterman, Bogda Koczwara

Zitieren

APA

Kanter, N. G., Cohen-Woods, S., Balfour, D. A., Burt, M. G., Waterman, A. L., & Koczwara, B. (2024). Hypothalamic–Pituitary–Adrenal Axis Dysfunction in People With Cancer: A Systematic Review. Cancer Medicine, 13(22). https://doi.org/10.1002/cam4.70366

Vancouver

Kanter NG, Cohen-Woods S, Balfour DA, Burt MG, Waterman AL, Koczwara B. Hypothalamic–Pituitary–Adrenal Axis Dysfunction in People With Cancer: A Systematic Review. Cancer Medicine. 2024;13(22). doi:10.1002/cam4.70366

BibTeX
@article{Kanter2024,
  author = {Kanter, Natalie G and Cohen-Woods, Sarah and Balfour, David A and Burt, Morton G and Waterman, Alison L and Koczwara, Bogda},
  title = {Hypothalamic–Pituitary–Adrenal Axis Dysfunction in People With Cancer: A Systematic Review},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {22},
  doi = {10.1002/cam4.70366}
}
Kostenlos starten →